HealthQuill MDMA
Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory body, according to the company.
Drugs Health Pharma

US regulator rejects Lykos’s MDMA therapy, wants more data 

Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory.

Read More
MDMA-assisted psychotherapy is a breakthrough in the treatment of PTSD, but without proper monitoring and documentation, we are inviting trouble.
Drugs Health Opinion Pharma

Opinion: Ecstasy drug-driven PTSD treatment faces tough questions

MDMA-assisted psychotherapy is a breakthrough in the treatment of PTSD, but without proper monitoring and documentation, we are inviting trouble.

Read More
Australia became the first country to allow authorized psychiatrists to prescribe psychedelic substances psilocybin and methylenedioxy-methamphetamine (MDMA) for the treatment of certain mental health conditions.
Drugs Health Pharma

Australia first to allow ecstasy, psilocybin as psychedelics prescriptions

HQ Team July 4, 2023: Australia became the first country to allow authorized psychiatrists to prescribe psychedelic substances psilocybin and methylenedioxy-methamphetamine (MDMA) for.

Read More